Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Feldstein PJ: Health Care Economics, 5th ed. Albany, NY, Delmar Publishers, Inc., 1999.
Phelps, CE: Health Economics. Reading, MA, Addison-Wesley Co., 1999.
Folland S, Goodman AC, Stano M: The Economics of Health and Health Care. Upper Saddle River, NJ, Prentice Hall, 1997.
Drummond MF, O’Brien CP, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. New York, Oxford University Press, Inc., 1997.
Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost Effectiveness in Health andMedicine. New York, Oxford University Press, 1996
Tolley G, Kenkel D, Fabian R: Valuing Healthfor Policy: An Economic Approach. Chicago, The University of Chicago Press, 1994.
Sloan FA: Valuing Health Care. New York, Cambridge University Press, 1996.
Anderson DW, Bowland BJ, Cartwright WS, Bassin G: Service-level costing of drug abuse treatment. J Subst Abuse Treat 15(3): 201–211, 1998.
French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat 14(5):445–455, 1997.
Rajkumar AS, French MT: Drug use, crime costs, and the economic benefits of treatment. J Quant Criminol 13(2):291–323, 1997.
Cohen MA: The monetary value of saving a high risk youth. J Quant Criminol 14(1):5–33, 1998.
Kenkel D: On valuing morbidity, cost-effectiveness analysis, and being rude. J Health Econ 16:749–757, 1997.
French MT, Mauskopf JA, Teague JL, Roland J: Estimating the dollar value of health outcomes from drug abuse interventions. Med Care 34(9):890–910, 1996b.
Fuchs VR: The future of health economics. J Health Econ (forthcoming).
National Institutes of Health: Office of Extramural Research (OER). Award data, (on-line), available: http://grants.nih.gov/grants/award/award.htm
Agency for Health Care Research and Quality: Funding opportunities. (on-line), available: http://www.ahcpr.gov/fund.
Center for Disease Control and Prevention: Procurement and grants office. (on-line), available: http://www.cdc.gov/od/pgo/funding/grantmain.htm.
National Institutes of Health: National Institute on Drug Abuse. Initial review group roster. (on-line), available: http://www.nida.nih.gov/IRGCouncil/IRGRosterF.html.
National Institutes of Health: National institute on alcohol abuse and alcoholism. Scientific review groups. (on-line), available: http://silk.nih.gov/silk/niaaal/grants/subroste.html.
National Institutes of Health: National Institute of Mental Health Special Emphasis Panel. Services Research Review Committee (SRV). (on-line), available: http://www.nimh.nih.gov/peer/srv.htm.
Robert Wood Johnson Foundation (RWJ). 2000. Substance abuse policy research program (on-line), available: http://www.phs.wfubmc.edu/sshp/rwj/funded.htm.
Mullahy J, Sindelar J: Employment, unemployment, and problem drinking. J Health Econ 15:409–434, 1996.
Dee TS: The complementarity of teen smoking and drinking. J Health Econ 18:709–763, 1999.
Norton EC, Lindrooth RC, Ennet ST: Controlling for the endogeneity of peer substance use on adolescent alcohol and tobacco use. Health Econ 75(5):439–53, 1998.
Buchmueller TC, Zuvekas SH: Drug use, drug abuse, and labour market outcomes. Health Econ 7(1):81–85, 1998.
Pacula RL: Does increasing the beer tax reduce marijuana consumption? J Health Econ 17:557–585, 1998.
Grossman M, Chaloupka FJ: The demand for cocaine by young adults: A rational addiction approach. J Health Econ 17:427–474, 1998.
French MT, McGeary KA: Estimating the economic cost of substance abuse treatment. Health Econ 6:539–544, 1997.
Sturm, R: Cost and quality trends under managed care: Is there a learning curve in behavioral health carve-out plans? J Health Econ 18:593–604, 1999.
Evans WN, Farrelly MC, Montgomery E: Do workplace smoking bans reduce smoking? Am Econ Rev 89(4):728–747, 1999.
Blendon RJ, Young JT: The public and the war on illicit drugs. JAMA 279(11):827–832, 1998
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine: Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276:1253–1258, 1996.
Curry SJ, Grothaus LC, McAfee T, Pabiniak C: Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 339(10), 1998.
Sturm R: How expensive is unlimited mental health care coverage under managed care? JAMA 278(18):1533–1537,1997.
Labeaga JM: A double-hurdle rational addiction model with heterogeneity: Estimating the demand for tobacco. J Econometrics 93(1):49, 1999.
Chaloupka FJ, Wechsler H: Price, tobacco control policies and smoking among young adults. J Health Econ 16:359–373, 1997.
Chaloupka FJ, Wechsler H: Binge Drinking in College: The impact of price, availability, and alcohol control policies. Contemp Econ Policy 14(4):112–124, 1996.
Manning WG, Blumberg L, Moulton LH: The demand for alcohol: The differential response to price. J Health Econ 14:123–148, 1995.
Ruhm CJ: Alcohol policies and highway vehicle fatalities. J Health Econ 15:435–454, 1996.
Barnett PG, Swindle RW: Cost-effectiveness of inpatient substance abuse treatment. Health Serv Res 32(5):615–629, 1997.
Chaloupka FJ, Saffer H, Grossman M: Alcohol-control policies and motor-vehicle fatalities. J Legal Stud 22(1):161–186, 1993.
Sindelar JL, Manning WG Jr: Cost-benefit and cost-effectiveness analysis: Issues in the evaluation of the treatment of illicit drug abuse, in JA Egertson, DM Fox AI Leshner (eds), Treating Drug Abusers Effectively. Malden, Blackwell Publishers, 1997.
Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfield R, Stine S, Cooney NL, Rosenheck RA, Li SH, Kosten TR: Day treatment versus enhanced standard methadone services for opiod-dependent patients: A comparison of clinical efficacy and cost. Am Psychiatry 156(1):27–33, 1999.
Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL: Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings, Med Care 38(1):7–18, 2000.
Gill AM, Michaels RJ: Does drug use lower wages? Ind Labor Rel Rev 45(3):419–434, 1992.
Kaestner R: New estimates of the effect of marijuana and cocaine use on wages. Ind Labor Rel Rev 47(3):454–470, 1994.
McGuire TG, Ruhm CJ: Workplace drug abuse policy. J Health Econ, 1993.
Zarkin GA, French MT, Mroz T, Bray JW: Alcohol use and wages: New results from the National Household Survey on Drug Abuse. J Health Economics 17(1):53–68, 1998.
French, MT, Zarkin GA: Is moderate alcohol use related to wages? Evidence from four worksites. J Health Econ 14(3):319–344, 1995.
McGeary KA, French MT: Illicit drug use and emergency room utilization. Health Serv Res (forthcoming).
French MT, McGeary KA, Chitwood DD, McCoy CB: Chronic illicit drug use, health services utilization, and the cost of medical care. Soc Sci Med (forthcoming).
Zarkin GA, Dunlap JL: Implications of managed care for methadone treatment. Findings from five case studies in New York. J Subst Abuse Treat 17(1–2):25–35, 1999.
McCarty D, Frank RG, Denmead GC: Methadone maintenance and state medicaid managed care programs. Milbank Q 77(3):341, 1999.
Frank RG, McGuire TG: Estimating costs of mental health and substance abuse coverage. Health Affairs 14(3):102–115, 1995.
Sturm R, Gresenz C, Sherbourne C, Minnium K, Klap R, Bhattacharya J, Farley D, Young AS, Burnam MA, Wells KB: The design of healthcare for communities: A study of healthcare delivery for alcohol, drug abuse, and mental health conditions. Inquiry 36(2):221–33, 1999.
Schoenbaum M, Zhang W, Sturm R: Costs and utilization of substance abuse care in a privately insured population under managed care. Psychiatr Serv 49:1583–1578, 1998.
Sturm R, Zhang W, Schoenbaum M: How expensive are unlimited substance abuse benefits under managed care. J Behav Health Serv Res 26(2):203–210, 1999.
Grossman M: On the concept of health capital and the demand for health. J Political Econ 80:223–255, 1972.
Becker GS, Murphy KM: A theory of rational addiction. J Political Econ 96:675–700,1988.
Becker GS, Grossman M, Murphy K: Rational addiction and the effect of price on consumption. Am Econ Rev 81(2):237–241, 1991.
Becker GS, Grossman M, Murphy K: An empirical analysis of cigarette addiction. Am Econ Rev 84(3):396–418, 1994.
Chaloupka FJ: Rational addictive behavior and cigarette smoking. J Political Econ 91(4):722–742, 1991.
Rosenzweig MR, Schultz TP: Estimating a household production function: Heterogeneity, the demand for health inputs and their effects on birth weight. J Political Econ 91(5):723–746, 1983.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
French, M.T. (2002). Overview. In: Alcoholism. Recent Developments in Alcoholism, vol 15. Springer, Boston, MA. https://doi.org/10.1007/978-0-306-47193-3_11
Download citation
DOI: https://doi.org/10.1007/978-0-306-47193-3_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46441-6
Online ISBN: 978-0-306-47193-3
eBook Packages: Springer Book Archive